Supply-chain overlap

direct ties · both sidesSources

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Shared 0

No disclosed counterparties: INAB.

Only INAB 0

None

Role chip = supplier or customerSource: SEC EDGAR

AMGNAmgen Inc

460.55+0.06%· post 460.42

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

INABIN8BIO, Inc.

0.97+16.87%· post 0.97

ClosedNov 6 '26

Mkt cap$10.0MRevenue—Revenue—

vs

Compare

ClosedNov 6 '26

AMGNAmgen Inc

vs

INABIN8BIO, Inc.

460.55+0.06%post 460.42

Price

0.97+16.87%post 0.97

$249.0B

Mkt cap

$10.0M

Q3 FY26$10.4B

Revenue

—

FY25$36.8B

Revenue

—

AMGN compared with INAB: revenue, margins and what each company keeps, and the suppliers and customers both name